In this general method for measuring the concentrations of neurotransmitters in body fluids by "high performance" liquid chromatography (HPLC), the procedures for extracting different biogenic amines from body fluids vary, but the basic chromatographic conditions are the same for all. We use citric/formic acid buffer as the mobile phase, a C18 column, and an electrochemical detector. Specificity is better than in previously reported methods. Because of its excellent cost efficiency, we consider this to be the method of choice for quantifying biogenic amines.
Reagents
Alumina from Sigma Chemical Co., St. Louis, MO, was further purified (11). NE, E, DHBA, NMN, and VMA were also from Sigma Chemical Co. The 400 mgfL stock solutions for standards were made up in perchioric acid solution, which contained 0.1 mol of perchloric acid, 5 mmol of EDTA, and 0.5 mmol of sodium metabisulfite per liter of "HPLCgrade" water. For the procedures we used Tris buffer containing 1 mol of Tris base, 20 mmol of EDTA, and 10 mmol of sodium metabisuffite per liter. The pH was adjusted to 8. 6 with concentrated
HC1.

Sample Collection
Blood from normal subjects and patients with hypertension was collected into heparinized tubes. The plasma was separated by centrifugation (4 #{176}C, 15 miii, 2000 x g), then stored at -20 #{176}C until it was assayed (no longer than 14 days). Urine specimens were collected for 24 h into a container with 15 mL of 6 molJL HC1 as preservative. After the collection, we adjusted the pH to 1.5, when necessary, with concentrated HC1. The urines were kept at 4#{176}C until assayed.
Extraction of Biogenic Amines
Plasma catecholamines. Add 1 mL of plasma to a 5-mL conical tube containing approximately 15 mg of alumina. Then add 620 pg of DHBA (internal standard) and 1 mL of Tris buffer and agitate for 10 mm. Centrifuge in a refrigerated centrifuge (2000 x g) for 10 mm and discard the supernate. Wash the alumina three times with 1 mL of cold water. After removing and discarding the last wash of water, add 125 tL of the perchloric acid solution and vortexmix for 5 mm. Centrifuge again and remove the supernate to a separate tube, which is kept on ice until sample injection. Inject 100 pL of the sample onto the column.
To measure catecholanunes in urine, use 25 L of acidified urine specimen and elute with 400 L of the perchioric acid solution. Use 100 L of the sample for injection. Otherwise, the urine extraction is the same as for plasma.
Pkzs,naNMN. To 2.5 mL of plasma in a 15-mL tube, add 6 mL of 0.3 mol/L trichioroacetic acid (TCA) and mix vigorously; let stand for 15 mm at room temperature.
Centrifuge the precipitate at 2000 x g and apply the supernate to a 3 x 0.4 cm Dowex-50 (H) column. Wash the precipitate with 2 mL of 0.3 molIL TCA, centrifuge, and apply this supernate also to the column. Wash the column twice with 10 mL of water and elute the NMN with two 1-mL aliquots of 4 mol/L NH4OH containing 240 g of methanol per liter. Dry the eluate under nitrogen gas, and dissolve the residue in 125 L of the perchloric acid solution. Inject 100 pL for analysis.
To determine NMN in urine, mix 0.1 mL of acidified urine with TCA and proceed as above. After drying, dissolve the residue in 1 mL of perchioric acid solution. HC1, 20 mg of NaCl, and 400 iL of ethyl acetate, then vortex-mix for 1 mm. Centrifuge, then transfer 200 p.L of the ethyl acetate layer to a 4-mL tube and add 1 mL of the perchloric acid solution. Vortex-mix and centrifuge again (1000 x g, 10 mm) and remove any trace of remaining ethyl acetate in a stream of nitrogen gas. Keep the samples on ice until injection. Inject 100 j.iL for analysis.
Results
The conditions for the determination of plasma and urinary NE, E, and NMN, and urinary VMA are identical. Therefore, we can inject extracts from plasma and urinary samples in succession without any delay. Figures 1-3 show the typical chromatograms of NE, E, NMN, and VMA from standards and from actual plasma and urine samples. Sensitivity, specificity, and reproducibility are the three most important criteria for a reliable assay. Table 1 shows the current generated by 500 pg of individual biogemc amunes and the amount of amines that deflected the current by 0.1 nit. At a full-scale range-which is commonly used-a 0.1-nA change in current produces a peak 10 mm high. Because a 4-to 5-mm change in the height of the peak can be easily detected, we used a 3-to 4-mm change as the limit of detection, i.e., the amount of amine that can be detected with better than 10% accuracy (right-hand column, Table 1 ). The sensitivity of the assay is generally related to the background current, which depends on the applied potential; therefore, it is important to use the lowest possible potential to achieve the lowest background current. We used 650-mV potential, which produced a background current of 1.2-5 nit. 
Sensitivity
Specificity
Certain antihypertensive drugs may interfere with some of the methods used to quantif' catecholamines. Therefore, the patients would have to stop these medications. Table 2 shows the concentrations of NE + E in the urine of patients on methyldopa (Aldomet) as measured by HPLC and by fluorometric method (11). Labetalol also interferes with the measurement of catecholamines (16, 17) . The following antihypertensive drugs showed no interference with the HPLC method: methyldopa, propranolol, labetalol, catopril, hydrochlorothiazide, sulphinalol, trazodone (Desyrel), bucindolol, esmolol, yohimbine, guanadrel, and minoxidil.
Reproducibility
The coefficients of variation (CV) for the assay of plasma and urinary biogemc ainines are shown in Table 3 . The interassay CVs for plasma NE and E are the same as the
intra-assay
CVs. This may be due to the higher concentration of biogenic amines in plasma used to establish the interassay CV. When the same amount of standard was injected several times (at least eight), the CV was <1%. Therefore, we assume that the largest error in the assay is introduced during the extraction procedures.
When NE and E are quantified in plasma and urine, DHBA is used as an internal standard. To validate the use of DHBA as an internal standard, we added 100, 200, and 500 pg of NE, E, and DHBA to a 1-mL pooled specimen of plasma. After extraction and measurement of these amines, the recovery was calculated. Means and standard deviations for the recoveries at different concentrations are shown in Table 4 . These values are not statistically different. When 4-hydroxy-3-methoxybenzylainine and 5-hydroxy-2-indolecarboxylic acid were used as internal standards for NMN and VMA, respectively, the recoveries were different (25). This may be due to the lower potential (650 mV) that we used in order to minimize the background. Therefore, the recovery was calculated from the difference between the sample and the sample plus the standard rather than by using a costandard.
Discussion
In this method the neurotransmitters and their metabolites were extracted from plasma and urine before they were subjected to HPLC. All extractions were simple and timeeffective. The error rate was less than for other assays, in part owing to the simplicity of the extractions. This is reflected in the low interassay CV. The sensitivity of the assay allows measurement of NE, E, and NMN from plasma, which may be useful in assessing sympathetic nervous system activity. The several antihypertensive drugs we tested did not interfere with the assay. It is not necessary to withhold medication from the patient before collecting the fluids for assay of the amines and VMA. The reproducibility of the assays for the biogenic amines appears to be better than that for either radioenzymatic assay or spectrometric assay. Table 5 gives the correlation coefficients, the intercepts, and the slopes for measurement of biogemc amines by these methods as compared with HPLC (see Figure 4) . Measurement of plasma catecholamines and NMN is more 
